111 related articles for article (PubMed ID: 9686931)
1. Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity.
Winkler G; Salamon F; Salamon D; Speer G; Simon K; Cseh K
Diabetologia; 1998 Jul; 41(7):860-1. PubMed ID: 9686931
[No Abstract] [Full Text] [Related]
2. Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity.
Winkler G; Salamon F; Harmos G; Salamon D; Speer G; Szekeres O; Hajós P; Kovács M; Simon K; Cseh K
Diabetes Res Clin Pract; 1998 Dec; 42(3):169-74. PubMed ID: 9925347
[TBL] [Abstract][Full Text] [Related]
3. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
Hamaguchi T; Fukushima H; Uehara M; Wada S; Shirotani T; Kishikawa H; Ichinose K; Yamaguchi K; Shichiri M
Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
[TBL] [Abstract][Full Text] [Related]
4. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus.
Mishima Y; Kuyama A; Tada A; Takahashi K; Ishioka T; Kibata M
Diabetes Res Clin Pract; 2001 May; 52(2):119-23. PubMed ID: 11311966
[TBL] [Abstract][Full Text] [Related]
5. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.
Mather KJ; Paradisi G; Leaming R; Hook G; Steinberg HO; Fineberg N; Hanley R; Baron AD
Diabetes Metab Res Rev; 2002; 18(2):118-26. PubMed ID: 11994903
[TBL] [Abstract][Full Text] [Related]
6. [The role of gastrin in regulating insulin and glucagon secretion in patients with diabetes mellitus].
Starosel'tseva LK; Kniazeva AP; Belovalova IM; Abduraimova GR
Probl Endokrinol (Mosk); 1988; 34(4):20-5. PubMed ID: 3057484
[TBL] [Abstract][Full Text] [Related]
7. Are the results really different?
Reaven GM
Diabetes Care; 2000 Jul; 23(7):1040. PubMed ID: 10895876
[No Abstract] [Full Text] [Related]
8. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
Herlihy OM; Barrow BA; Grant PJ; Levy JC
Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus.
Katsuki A; Sumida Y; Murashima S; Murata K; Takarada Y; Ito K; Fujii M; Tsuchihashi K; Goto H; Nakatani K; Yano Y
J Clin Endocrinol Metab; 1998 Mar; 83(3):859-62. PubMed ID: 9506740
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
[TBL] [Abstract][Full Text] [Related]
11. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat.
Hamann A; Benecke H; Le Marchand-Brustel Y; Susulic VS; Lowell BB; Flier JS
Diabetes; 1995 Nov; 44(11):1266-73. PubMed ID: 7589822
[TBL] [Abstract][Full Text] [Related]
12. The clinical and hormonal (C-peptide and glucagon) profile and liability to ketoacidosis during nutritional rehabilitation in Ethiopian patients with malnutrition-related diabetes mellitus.
Abdulkadir J; Mengesha B; Welde Gebriel Z; Keen H; Worku Y; Gebre P; Bekele A; Urga K; Taddesse AS
Diabetologia; 1990 Apr; 33(4):222-7. PubMed ID: 2112100
[TBL] [Abstract][Full Text] [Related]
13. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
14. [Plasma glucagon and insulin profile in obese non-diabetic and non-insulin-dependent diabetic patients on a daily 800 calorie diet].
Balázsi I; Varsányi-Nagy M; Nagy K
Orv Hetil; 1986 Aug; 127(33):2009-13. PubMed ID: 3537903
[No Abstract] [Full Text] [Related]
15. Tumor necrosis factor alpha: a key component of the obesity-diabetes link.
Hotamisligil GS; Spiegelman BM
Diabetes; 1994 Nov; 43(11):1271-8. PubMed ID: 7926300
[TBL] [Abstract][Full Text] [Related]
16. Insulin mediators in man: effects of glucose ingestion and insulin resistance.
Shashkin PN; Shashkina EF; Fernqvist-Forbes E; Zhou YP; Grill V; Katz A
Diabetologia; 1997 May; 40(5):557-63. PubMed ID: 9165224
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum tumor necrosis factor-alpha and endothelin 1 levels correlate with increased C-peptide concentration in android type obesity.
Winkler G; Lakatos P; Nagy Z; Speer G; Salamon F; Szekeres O; Kovács M; Cseh K
Diabetes Care; 1998 Oct; 21(10):1778-9. PubMed ID: 9773752
[No Abstract] [Full Text] [Related]
18. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
[TBL] [Abstract][Full Text] [Related]
19. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients.
McGill JB; Schneider DJ; Arfken CL; Lucore CL; Sobel BE
Diabetes; 1994 Jan; 43(1):104-9. PubMed ID: 8262307
[TBL] [Abstract][Full Text] [Related]
20. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
